The expression of PIM kinases (PIM-1, PIM-2, and PIM-3) was analyzed in RA, PsA, and axSpA patient samples naïve to biologics or JAKi, some of which already received prior treatments with cDMARDs or corticosteroids. This evidence concerns the gene PIM2 and rheumatoid arthritis.